Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microwave Thermolysis vs Botulinum Toxin A for Axillary Hyperhidrosis
NCT05057117Phase 4Completed
- Start
- Sep 2021
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms). Primary endpoint: Subjective change in axillary sweat at 6 months. Started Sep 2021; status: completed.
Beyond the preview
Go deeper on NCT05057117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05057117.